Skip to main content

Table 1 OPA GMTs (95% Confidence Interval) — Evaluable Population

From: Controlling Pneumococcal Disease around the Globe

Serotype

Pre-vaccination

1-month post-dose 2

1-year post-dose 2

n = 95–131

n = 89–118

n = 55–73

1

7

(5.7–8.8)

78

(59.5–101.2)

25

(17.5–35.4)

3

13

(10.1–17.5)

105

(87.2–127.2)

31

(22.6–42.6)

4

215

(129.6–357.2)

3051

(2536.7–3670.3)

1107

(764.4–1602.2)

5

10

(7.8–13.9)

273

(213.9–349.2)

102

(70.5–148.0)

6A

246

(149.0–404.8)

7633

(6439.6–9048.6)

2485

(1921.2–3214.3)

6B

626

(377.5–1037.4)

7601

(6392.6–9038.6)

3412

(2746.4–4238.7)

7F

344

(220.5–537.9)

3723

(3276.2–4230.1)

2166

(1861.4–2519.3)

9V

234

(137.6–398.7)

3467

(2784.0–4317.6)

1690

(1157.8–2465.5)

14

628

(425.8–925.7)

2081

(1770.5–2446.0)

1595

(1281.6–1984.9)

18C

426

(235.7–771.4)

5271

(4267.8–6510.1)

1604

(1107.2–2324.2)

19A

137

(100.0–187.4)

1314

(1084.4–1592.6)

589

(449.4–771.1)

19F

94

(55.0–160.7)

1507

(1139.9–1992.2)

620

(376.6–1020.4)

23F

34

(21.5–54.8)

2330

(1880.4–2887.0)

924

(654.2–1306.1)